mecamylamine and cyclosporine

mecamylamine has been researched along with cyclosporine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	2 (66.67)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Greengard, P; Hamada, M; Higashi, H; Nairn, AC; Nishi, A	1

Reviews

1 review(s) available for mecamylamine and cyclosporine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

2 other study(ies) available for mecamylamine and cyclosporine

Article	Year
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Differential regulation of dopamine D1 and D2 signaling by nicotine in neostriatal neurons. Journal of neurochemistry, 2004, Volume: 90, Issue:5 Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Benzazepines; Blotting, Western; Bungarotoxins; Cyclosporine; Dihydro-beta-Erythroidine; Dizocilpine Maleate; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; In Vitro Techniques; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Models, Neurological; Neostriatum; Nerve Tissue Proteins; Neurons; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Phosphoproteins; Phosphorylation; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Tetrodotoxin; Threonine	2004

Article

Year

Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.

Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012

Differential regulation of dopamine D1 and D2 signaling by nicotine in neostriatal neurons.

Journal of neurochemistry, 2004, Volume: 90, Issue:5

Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Benzazepines; Blotting, Western; Bungarotoxins; Cyclosporine; Dihydro-beta-Erythroidine; Dizocilpine Maleate; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; In Vitro Techniques; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Models, Neurological; Neostriatum; Nerve Tissue Proteins; Neurons; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Phosphoproteins; Phosphorylation; Raclopride; Receptors, Dopamine D1; Receptors, Dopamine D2; Tetrodotoxin; Threonine

2004